Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox extension in pediatric beta-thalassemia major
NCT00390858Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2003
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of deferasirox in iron overload, sponsored by Novartis. Started Sep 2003; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT00390858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390858.